|
NUF2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.67603733511623E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.7275999519839E-09 |
| Normal-vs-Stage2 |
7.181200E-04 |
| Normal-vs-Stage3 |
3.91259999954485E-08 |
| Normal-vs-Stage4 |
4.056100000005E-05 |
| Stage1-vs-Stage2 |
3.974200E-01 |
| Stage1-vs-Stage3 |
1.151700E-02 |
| Stage1-vs-Stage4 |
2.215100E-03 |
| Stage2-vs-Stage3 |
3.716200E-01 |
| Stage2-vs-Stage4 |
1.031550E-02 |
| Stage3-vs-Stage4 |
2.799600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.46003259166628E-12 |
| Normal-vs-AfricanAmerican |
1.039790E-04 |
| Normal-vs-Asian |
6.755700E-02 |
| Caucasian-vs-AfricanAmerican |
8.162800E-03 |
| Caucasian-vs-Asian |
6.139800E-01 |
| AfricanAmerican-vs-Asian |
2.502600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.73740022368918E-10 |
| Normal-vs-Female |
2.2353999762359E-09 |
| Male-vs-Female |
3.311900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.658000E-03 |
| Normal-vs-Age(41-60Yrs) |
4.02300004420653E-09 |
| Normal-vs-Age(61-80Yrs) |
5.17349999507033E-08 |
| Normal-vs-Age(81-100Yrs) |
8.809300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.000400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.113800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.187410E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.989800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.465600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.698380E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.621400E-03 |
| Normal-vs-Grade 2 |
1.06090003448855E-09 |
| Normal-vs-Grade 3 |
1.5218004634221E-10 |
| Normal-vs-Grade 4 |
8.09510000000513E-05 |
| Grade 1-vs-Grade 2 |
2.014300E-02 |
| Grade 1-vs-Grade 3 |
1.016320E-04 |
| Grade 1-vs-Grade 4 |
7.032100E-04 |
| Grade 2-vs-Grade 3 |
6.303400E-03 |
| Grade 2-vs-Grade 4 |
2.661500E-03 |
| Grade 3-vs-Grade 4 |
1.334430E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.56310000001925E-07 |
| Normal-vs-ccB subtype |
7.1475999996462E-07 |
| ccA subtype-vs-ccB subtype |
4.176300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.52230031200429E-10 |
| Normal-vs-N1 |
3.655900E-03 |
| N0-vs-N1 |
2.883600E-02 |
|
|
